首页> 外文期刊>Behavioral and Brain Functions >Copy number variation of the SELENBP1 gene in schizophrenia
【24h】

Copy number variation of the SELENBP1 gene in schizophrenia

机译:精神分裂症中SELENBP1基因的拷贝数变异

获取原文
           

摘要

Background Schizophrenia is associated with rare copy-number (CN) mutations. Screening for such alleles genome-wide, though comprehensive, cannot study in-depth the causality of particular loci, therefore cannot provide the functional interpretation for the disease etiology. We hypothesized that CN mutations in the SELENBP1 locus could associate with the disorder and that these mutations could alter the gene product's activity in patients. Methods We analyzed SELENBP1 CN variation (CNV) in blood DNA from 49 schizophrenia patients and 49 controls (cohort A). Since CN of genes may vary among tissues, we investigated SELENBP1 CN in age- sex- and postmortem interval-matched cerebellar DNA samples from 14 patients and 14 controls (cohort B). Since CNV may either be de-novo or inherited we analyzed CNV of the SELENBP1 locus in blood DNA from 26 trios of schizophrenia probands and their healthy parents (cohort C). SELENBP1 mRNA levels were measured by real-time PCR. Results In cohort A reduced CN of the SELENBP1 locus was found in four patients but in none of the controls. In cohort B we found reduced CN of the SELENBP1 locus in two patients but in none of the controls. In cohort C three patients exhibited drastic CN reduction, not present in their parents, indicating de-novo mutation. A reduction in SELENBP1 mRNA levels in the postmortem cerebellar samples of schizophrenia patients was found. Conclusions We report a focused study of CN mutations in the selenium binding-protein1 (SELENBP1) locus previously linked with schizophrenia. We provide evidence for recurrence of decreased CN of the SELENBP1 locus in three unrelated patients' cohorts but not in controls, raising the possibility of functional involvement of these mutations in the etiology of the disease.
机译:背景精神分裂症与罕见的拷贝数(CN)突变相关。全基因组范围内等位基因的筛选尽管全面,但无法深入研究特定基因座的因果关系,因此无法为疾病病因学提供功能解释。我们假设SELENBP1基因座中的CN突变可能与该疾病有关,并且这些突变可能改变患者基因产物的活性。方法我们分析了49位精神分裂症患者和49位对照(队列A)的血液DNA中SELENBP1 CN的变异(CNV)。由于基因的CN在各组织之间可能不同,因此我们在14位患者和14位对照(队列B)的年龄,性别和验尸间隔匹配的小脑DNA样本中调查了SELENBP1 CN。由于CNV可能是新变异的或遗传的,因此我们分析了来自26个三重精神分裂症先证者及其健康父母(队列C)的血液DNA中SELENBP1基因座的CNV。通过实时PCR测量SELENBP1mRNA水平。结果队列中SELENBP1基因座的CN降低,但四名患者均未发现。在队列B中,我们发现2例患者的SELENBP1基因座的CN降低,但没有对照组。在队列C中,三名患者表现出CN的急剧降低,而在其父母中不存在,表明发生了新突变。发现精神分裂症患者的死后小脑样本中SELENBP1 mRNA水平降低。结论我们报道了一项针对先前与精神分裂症相关的硒结合蛋白1(SELENBP1)基因座中CN突变的集中研究。我们提供了证据表明,在三个无关患者队列中,但在对照组中,SELENBP1基因座的CN降低复发,从而增加了这些突变功能性参与疾病病因的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号